Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-18-012900

VP, Clinical&Translational Sc acquired 35,274 shares (option exercise)

  • VP, Clinical&Translational Sc gave up 2,882 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DeVinney Erick Wayne VP, Clinical&Translational Sc 2018-11-13 Option exercise +35,000 $2.74 $95,900 40,018 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2018-11-13 Shares withheld for taxes −2,882 $33.28 $95,913 37,136 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2018-11-13 Option exercise +274 $0.27 $74 37,410 D
Derivatives
DeVinney Erick Wayne VP, Clinical&Translational Sc 2018-11-13 Option exercise · Employee Stock Option (right to purchase) −35,000 0 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2018-11-13 Option exercise · Employee Stock Option (right to purchase) −274 0 D
Loading xslF345X03/edgar.xml…